Discovering and developing novel therapeutics through clinical proof of concept
Founded by a group of accomplished biopharmaceutical professionals who have collaborated extensively on early-stage drug discovery and development projects.
PHT has the resources to identify strong preclinical therapeutic opportunities with addressable markets, valid science, druggable targets, and clear regulatory precedent.
The Company's strong business model, its core leadership and drug development team enable efficient use of resources and capital, and creation of strong IP leading to early clinical proof-of-concept and successful exits.
Copyright © 2022 Potrero Hill Therapeutics - All Rights Reserved.